penicillin v has been researched along with zithromax in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (30.30) | 18.2507 |
| 2000's | 12 (36.36) | 29.6817 |
| 2010's | 10 (30.30) | 24.3611 |
| 2020's | 1 (3.03) | 2.80 |
| Authors | Studies |
|---|---|
| Abraham, MH; Acree, WE; Ibrahim, A | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Cimperman, J; Ruzic, E; Strle, F | 1 |
| Hooton, TM | 1 |
| Pichichero, ME; Rodewald, LE | 1 |
| Hamill, J | 1 |
| Chiesa, C; Pacifico, L; Pataracchia, M; Ranucci, A; Savignoni, F; Scopetti, F | 1 |
| Heynen, G; Schaad, UB | 1 |
| O'Doherty, B | 1 |
| Hayle, R; Høivik, HO; Lingaas, E; Odegård, T | 1 |
| Chiesa, C; Pacifico, L | 1 |
| Allerberger, F; Eigentler, A; Jakob-Sölder, B; Steininger, C | 1 |
| Bingen, E; Boucherat, M; Brahimi, N; Cohen, R; De La Rocque, F; Deforche, D; Levy, C; Navel, M; Palestro, B; Reinert, P; Robert, M | 1 |
| Altwegg, M; Kellerhals, P; Schaad, UB | 1 |
| Arnez, M; Luznik-Bufon, T; Pleterski-Rigler, D; Ruzić-Sabljić, E; Strle, F | 1 |
| Frimodt-Møller, N; Konradsen, HB; Lous, J; Nielsen, HU | 1 |
| Palmer, NO | 1 |
| Chhatwal, GS; Kaplan, EL; Rohde, M | 1 |
| Arnez, M | 1 |
| Beovic, B; Blanche, S; Brousse, N; Galmiche, L; Güngör, T; Holland, SM; Kayal, S; Lopatin, U; Mahlaoui, N; Reichenbach, J; Seger, RA; Siler, U; Zbinden, R | 1 |
| Alexander, JJ; Mathew, J; Mosholder, AD; Nambiar, S; Smith, H | 1 |
| Hviid, A; Pasternak, B; Svanström, H | 2 |
| Steurer, J | 1 |
| Jhund, PS; McMurray, JJ | 1 |
| Brass, EP | 1 |
| Mosholder, AD; Nambiar, S | 1 |
| Droitcourt, C; Dupire, G; Hughes, C; Le Cleach, L | 1 |
| Karampatakis, N; Karampatakis, T; Tsergouli, K | 1 |
3 review(s) available for penicillin v and zithromax
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Antistreptococcal interventions for guttate and chronic plaque psoriasis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Ascorbic Acid; Azithromycin; Child; Erythromycin; Humans; Middle Aged; Penicillin V; Psoriasis; Randomized Controlled Trials as Topic; Rifampin; Streptococcal Infections; Tonsillectomy; Vitamins | 2019 |
Efficacy of antimicrobials or placebo compared to amoxicillin-clavulanate in children with acute otitis media: a systematic review.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefaclor; Cefdinir; Child; Humans; Infant; Otitis Media; Penicillin V; Treatment Outcome | 2023 |
11 trial(s) available for penicillin v and zithromax
| Article | Year |
|---|---|
Erythema migrans: comparison of treatment with azithromycin, doxycycline and phenoxymethylpenicillin.
Topics: Adolescent; Adult; Aged; Azithromycin; Doxycycline; Erythema Chronicum Migrans; Erythromycin; Humans; Male; Middle Aged; Penicillin V; Prospective Studies; Random Allocation | 1992 |
A comparison of azithromycin and penicillin V for the treatment of streptococcal pharyngitis.
Topics: Abdominal Pain; Adult; Azithromycin; Erythromycin; Female; Humans; Male; Penicillin V; Pharyngitis; Streptococcal Infections | 1991 |
Compliance with antibiotic therapy: a comparison of deuterium oxide tracer, urine bioassay, bottle weights, and parental reports.
Topics: Adolescent; Azithromycin; Child; Child, Preschool; Deuterium; Deuterium Oxide; Drug Packaging; Erythromycin; Female; Humans; Male; Parents; Patient Compliance; Penicillin V; Pharyngitis; Regression Analysis; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis; Water | 1993 |
Multicentre evaluation of azithromycin and penicillin V in the treatment of acute streptococcal pharyngitis and tonsillitis in children.
Topics: Acute Disease; Azithromycin; Child; Child, Preschool; Erythromycin; Female; Humans; Male; Penicillin V; Pharyngitis; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis | 1993 |
Comparative efficacy and safety of 3-day azithromycin and 10-day penicillin V treatment of group A beta-hemolytic streptococcal pharyngitis in children.
Topics: Azithromycin; Child; Child, Preschool; Female; Humans; Male; Penicillin V; Pharyngitis; Streptococcus | 1996 |
Evaluation of the efficacy, safety and toleration of azithromycin vs. penicillin V in the treatment of acute streptococcal pharyngitis in children: results of a multicenter, open comparative study. The Swiss Tonsillopharyngitis Study Group.
Topics: Acute Disease; Adolescent; Anti-Bacterial Agents; Azithromycin; Child; Child, Preschool; Female; Humans; Infant; Male; Penicillin V; Penicillins; Pharyngitis; Streptococcal Infections; Streptococcus pyogenes | 1996 |
Azithromycin versus penicillin V in the treatment of paediatric patients with acute streptococcal pharyngitis/tonsillitis. Paediatric Azithromycin Study Group.
Topics: Administration, Oral; Adolescent; Analysis of Variance; Anti-Bacterial Agents; Azithromycin; Chi-Square Distribution; Child; Child, Preschool; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Penicillin V; Penicillins; Pharyngitis; Prospective Studies; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis; Treatment Outcome | 1996 |
Efficacy and safety of azithromycin versus phenoxymethylpenicillin in the treatment of acute maxillary sinusitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Bacterial Agents; Azithromycin; Chi-Square Distribution; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Maxillary Sinusitis; Middle Aged; Penicillin V; Penicillins; Treatment Outcome | 1996 |
Comparison of two dosages of azithromycin for three days versus penicillin V for ten days in acute group A streptococcal tonsillopharyngitis.
Topics: Administration, Oral; Anti-Bacterial Agents; Azithromycin; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infant; Male; Penicillin V; Penicillins; Pharyngitis; Prospective Studies; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis; Treatment Outcome | 2002 |
Azithromycin versus penicillin V for treatment of acute group A streptococcal pharyngitis.
Topics: Administration, Oral; Anti-Bacterial Agents; Azithromycin; Child; Child, Preschool; Drug Administration Schedule; Female; Humans; Infant; Male; Penicillin V; Penicillins; Pharyngitis; Streptococcal Infections; Streptococcus pyogenes; Treatment Outcome | 2002 |
Solitary erythema migrans in children: comparison of treatment with azithromycin and phenoxymethylpenicillin.
Topics: Adolescent; Azithromycin; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Erythema Chronicum Migrans; Female; Humans; Infant; Male; Penicillin V; Slovenia; Treatment Outcome | 2002 |
19 other study(ies) available for penicillin v and zithromax
| Article | Year |
|---|---|
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Efficacy of three-day azithromycin vs. ten-day penicillin V in the treatment of streptococcal pharyngitis.
Topics: Anti-Bacterial Agents; Azithromycin; Clinical Trials as Topic; Drug Administration Schedule; Follow-Up Studies; Humans; Penicillin V; Penicillins; Pharyngitis; Prognosis; Streptococcal Infections | 1997 |
Treatment of pediatric patients with acute group A beta-hemolytic streptococcal tonsillopharyngitis.
Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Child; Child, Preschool; Drug Resistance, Microbial; Drug Tolerance; Humans; Infant; Microbial Sensitivity Tests; Penicillin V; Penicillins; Pharyngitis; Prospective Studies; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis | 1998 |
Nasopharyngeal pathogens in children with acute otitis media in a low-antibiotic use country.
Topics: Acute Disease; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Child; Child, Preschool; Denmark; Drug Utilization; Female; Humans; Infant; Male; Nasopharynx; Otitis Media, Suppurative; Penicillin V | 2004 |
Pharmaceutical prescribing for children. Part 3. Antibiotic prescribing for children with odontogenic infections.
Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; Erythromycin; Focal Infection, Dental; Humans; Metronidazole; Penicillin V | 2006 |
Reduced ability of penicillin to eradicate ingested group A streptococci from epithelial cells: clinical and pathogenetic implications.
Topics: Anti-Bacterial Agents; Azithromycin; Cell Line; Cephalothin; Clindamycin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Epithelial Cells; Erythromycin; Humans; Microbial Sensitivity Tests; Penicillin V; Streptococcus pyogenes | 2006 |
Antibiotic treatment of children with erythema migrans.
Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; Cefuroxime; Child; Erythema Chronicum Migrans; Humans; Penicillin V | 2007 |
Actinomyces in chronic granulomatous disease: an emerging and unanticipated pathogen.
Topics: Actinomyces; Actinomycosis; Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Bone Marrow Transplantation; Ceftriaxone; Child; Clindamycin; Communicable Diseases, Emerging; DNA, Ribosomal; Female; Granulomatous Disease, Chronic; Humans; Male; Meropenem; Penicillin G; Penicillin V; Polymerase Chain Reaction; Sulfamethoxazole; Thienamycins; Trimethoprim; Young Adult | 2009 |
Cardiovascular risks with azithromycin and other antibacterial drugs.
Topics: Anti-Bacterial Agents; Azithromycin; Cardiovascular Diseases; Death, Sudden, Cardiac; Female; Humans; Male; Penicillin V | 2013 |
Use of azithromycin and death from cardiovascular causes.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Cardiovascular Diseases; Cohort Studies; Denmark; Female; Humans; Infections; Male; Middle Aged; Penicillin V; Propensity Score; Registries; Risk; Young Adult | 2013 |
[Not Available].
Topics: Anti-Bacterial Agents; Azithromycin; Cardiovascular Diseases; Female; Humans; Male; Penicillin V | 2013 |
Cardiovascular risks with azithromycin.
Topics: Anti-Bacterial Agents; Azithromycin; Cardiovascular Diseases; Female; Humans; Male; Penicillin V | 2013 |
Cardiovascular risks with azithromycin.
Topics: Anti-Bacterial Agents; Azithromycin; Cardiovascular Diseases; Death, Sudden, Cardiac; Female; Humans; Male; Penicillin V | 2013 |
Cardiovascular risks with azithromycin.
Topics: Anti-Bacterial Agents; Azithromycin; Cardiovascular Diseases; Death, Sudden, Cardiac; Female; Humans; Male; Penicillin V | 2013 |
Cardiovascular risks with azithromycin.
Topics: Anti-Bacterial Agents; Azithromycin; Cardiovascular Diseases; Death, Sudden, Cardiac; Female; Humans; Male; Penicillin V | 2013 |